Loading...
Biosimilar medicines
Biological medicines have become indispensable in the treatment of patients with serious diseases such as cancer and inflammatory diseases. Biosimilars are medicines which are developed to be similar to existing biological medicines (the ‘reference product’). For the European market, they are approv...
Na minha lista:
| Udgivet i: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452401/ https://ncbi.nlm.nih.gov/pubmed/31157111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-001821 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|